238 related articles for article (PubMed ID: 25268801)
1. Combining MK626, a novel DPP-4 inhibitor, and low-dose monoclonal CD3 antibody for stable remission of new-onset diabetes in mice.
Ding L; Gysemans CA; Stangé G; Heremans Y; Yuchi Y; Takiishi T; Korf H; Chintinne M; Carr RD; Heimberg H; Pipeleers D; Mathieu C
PLoS One; 2014; 9(9):e107935. PubMed ID: 25268801
[TBL] [Abstract][Full Text] [Related]
2. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
3. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
[TBL] [Abstract][Full Text] [Related]
4. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
[TBL] [Abstract][Full Text] [Related]
5. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
[TBL] [Abstract][Full Text] [Related]
6. The effects of DPP-IV inhibition in NOD mice with overt diabetes.
Vargová L; Zacharovová K; Dovolilová E; Vojtová L; Cimburek Z; Saudek F
Folia Biol (Praha); 2013; 59(3):116-22. PubMed ID: 23890479
[TBL] [Abstract][Full Text] [Related]
7. Partial and transient modulation of the CD3-T-cell receptor complex, elicited by low-dose regimens of monoclonal anti-CD3, is sufficient to induce disease remission in non-obese diabetic mice.
Mehta DS; Christmas RA; Waldmann H; Rosenzweig M
Immunology; 2010 May; 130(1):103-13. PubMed ID: 20059577
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic use of a selective S1P1 receptor modulator ponesimod in autoimmune diabetes.
You S; Piali L; Kuhn C; Steiner B; Sauvaget V; Valette F; Clozel M; Bach JF; Chatenoud L
PLoS One; 2013; 8(10):e77296. PubMed ID: 24204793
[TBL] [Abstract][Full Text] [Related]
9. Homotaurine Treatment Enhances CD4
Tian J; Dang H; O'Laco KA; Song M; Tiu BC; Gilles S; Zakarian C; Kaufman DL
Immunohorizons; 2019 Oct; 3(10):498-510. PubMed ID: 31636084
[TBL] [Abstract][Full Text] [Related]
10. Long-term remission of diabetes in NOD mice is induced by nondepleting anti-CD4 and anti-CD8 antibodies.
Yi Z; Diz R; Martin AJ; Morillon YM; Kline DE; Li L; Wang B; Tisch R
Diabetes; 2012 Nov; 61(11):2871-80. PubMed ID: 22751694
[TBL] [Abstract][Full Text] [Related]
11. Exendin-4 modulates diabetes onset in nonobese diabetic mice.
Hadjiyanni I; Baggio LL; Poussier P; Drucker DJ
Endocrinology; 2008 Mar; 149(3):1338-49. PubMed ID: 18063685
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of carbonyl iron against multiple low-dose streptozotocin-induced diabetes in rodents.
Vujicic M; Saksida T; Mostarica Stojkovic M; Djedovic N; Stojanovic I; Stosic-Grujicic S
J Cell Physiol; 2018 Jun; 233(6):4990-5001. PubMed ID: 29215791
[TBL] [Abstract][Full Text] [Related]
13. Induction of active tolerance and involvement of CD1d-restricted natural killer T cells in anti-CD3 F(ab')2 treatment-reversed new-onset diabetes in nonobese diabetic mice.
Chen G; Han G; Wang J; Wang R; Xu R; Shen B; Qian J; Li Y
Am J Pathol; 2008 Apr; 172(4):972-9. PubMed ID: 18349126
[TBL] [Abstract][Full Text] [Related]
14. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
[TBL] [Abstract][Full Text] [Related]
15. Granzyme B is dispensable in the development of diabetes in non-obese diabetic mice.
Mollah ZU; Graham KL; Krishnamurthy B; Trivedi P; Brodnicki TC; Trapani JA; Kay TW; Thomas HE
PLoS One; 2012; 7(7):e40357. PubMed ID: 22792290
[TBL] [Abstract][Full Text] [Related]
16. α-Galactosylceramide ameliorates autoimmune diabetes in non-obese diabetic mice through a suppressive effect mediated by CD8+ T cells.
Chuang YP; Lin YC; Sytwu HK
Immunol Lett; 2011 Jul; 138(1):54-62. PubMed ID: 21392534
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor induces β-cell neogenesis from adult human pancreatic duct cells implanted in immunodeficient mice.
Suarez-Pinzon WL; Rabinovitch A
Cell Transplant; 2011; 20(9):1343-9. PubMed ID: 21396168
[TBL] [Abstract][Full Text] [Related]
18. Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice.
Sarikonda G; Sachithanantham S; Manenkova Y; Kupfer T; Posgai A; Wasserfall C; Bernstein P; Straub L; Pagni PP; Schneider D; Calvo TR; Coulombe M; Herold K; Gill RG; Atkinson M; Nepom G; Ehlers M; Staeva T; Garren H; Steinman L; Chan AC; von Herrath M
PLoS One; 2013; 8(2):e54712. PubMed ID: 23405091
[TBL] [Abstract][Full Text] [Related]
19. Surge in regulatory T cells does not prevent onset of hyperglycemia in NOD mice: immune profiles do not correlate with disease severity.
Kaminitz A; Mizrahi K; Askenasy N
Autoimmunity; 2014 Mar; 47(2):105-12. PubMed ID: 24328490
[TBL] [Abstract][Full Text] [Related]
20. Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W; Hussain S; Mi QS; Santamaria P; Delovitch TL
J Immunol; 2004 Oct; 173(7):4407-16. PubMed ID: 15383571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
